TXNDC5 and prostate carcinoma: TXNDC5 is involved in protein folding and chaperone activity and is abnormally expressed in many cancers, such as non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, colon cancer, and hepatocellular carcinoma [23].